The Skin Cancer Education and Research Foundation – Home › Forums › Intralesional immunotherapy › Side-effect management › Ocular herpes › Reply To: Ocular herpes
January 5, 2018 at 2:54 am #4599
Expert NurseVirginia Seery
Krista, my hesitation would be the need for chronic suppression with antivirals as this could potentially decrease the efficacy of T-VEC. However, if other options are limited or exhausted, it would be reasonable to consider with close monitoring for recurrent ocular symptoms.